CHINA PHARMA HOLDINGS, INC. Indefinite-lived Intangible Assets, Period Increase (Decrease)
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Indefinite-lived Intangible Assets, Period Increase (Decrease) of $0 for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-12-28.
Discontinued › Notes › Goodwill and Other
us-gaap:IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease · last filed 2015-12-28
- CHINA PHARMA HOLDINGS, INC. indefinite-lived intangible assets, period increase (decrease) for the quarter ending 2014-12-31 was -$470.62K, a 337.69% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. indefinite-lived intangible assets, period increase (decrease) for the quarter ending 2013-12-31 was $198.00K.
- CHINA PHARMA HOLDINGS, INC. indefinite-lived intangible assets, period increase (decrease) for the quarter ending 2013-09-30 was $4.08M.
- CHINA PHARMA HOLDINGS, INC. indefinite-lived intangible assets, period increase (decrease) for fiscal 2014 was -$714.70K.
- CHINA PHARMA HOLDINGS, INC. indefinite-lived intangible assets, period increase (decrease) for fiscal 2013 was -$298.63K.
| Period end | Indefinite-lived Intangible Assets, Period Increase (Decrease) 3 month | Indefinite-lived Intangible Assets, Period Increase (Decrease) 6 month | Indefinite-lived Intangible Assets, Period Increase (Decrease) 9 month | Indefinite-lived Intangible Assets, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2015-09-30 | $0.00 10-Q · filed 2015-12-28 | |||
| 2014-12-31 | -$470.62K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | -$714.70K 10-K · filed 2015-03-30 | ||
| 2014-09-30 | -$244.07K 10-Q · filed 2015-12-28 | |||
| 2013-12-31 | $198.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $4.27M derived: sum of 2 quarters · filed 2015-03-30 | -$298.63K 10-K · filed 2015-03-30 | |
| 2013-09-30 | $4.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$496.63K 10-Q · filed 2014-11-14 | ||
| 2013-06-30 | -$4.57M 10-Q · filed 2013-08-14 | |||
| 2012-06-30 | -$1.27M 10-Q · filed 2013-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |